Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma

Anton Pottegard; Sidsel Arnspang Pedersen; Sigrun Alba Johannesdottir Schmidt; Lisbet Rosenkrantz Holmich; Søren Friis; David Gaist

doi:10.1001/jamainternmed.2018.1652

Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma

Anton Pottegard, Sidsel Arnspang Pedersen, Sigrun Alba Johannesdottir Schmidt, Lisbet Rosenkrantz Holmich, Søren Friis, David Gaist

Research output: Contribution to journal › Letter › Research › peer-review

73 Citations (Scopus)

Original language	English
Journal	JAMA Internal Medicine
Volume	178
Issue number	8
Pages (from-to)	1120-1122
Number of pages	3
ISSN	2168-6106
DOIs	https://doi.org/10.1001/jamainternmed.2018.1652
Publication status	Published - 2018

Access to Document

10.1001/jamainternmed.2018.1652

Cite this

@article{468d5c2e970948e1a4d508789eabe683,

title = "Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma",

author = "Anton Pottegard and Pedersen, {Sidsel Arnspang} and Schmidt, {Sigrun Alba Johannesdottir} and Holmich, {Lisbet Rosenkrantz} and S{\o}ren Friis and David Gaist",

year = "2018",

doi = "10.1001/jamainternmed.2018.1652",

language = "English",

volume = "178",

pages = "1120--1122",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "The JAMA Network",

number = "8",

}

TY - JOUR

T1 - Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma

AU - Pottegard, Anton

AU - Pedersen, Sidsel Arnspang

AU - Schmidt, Sigrun Alba Johannesdottir

AU - Holmich, Lisbet Rosenkrantz

AU - Friis, Søren

AU - Gaist, David

PY - 2018

Y1 - 2018

U2 - 10.1001/jamainternmed.2018.1652

DO - 10.1001/jamainternmed.2018.1652

M3 - Letter

C2 - 29813157

VL - 178

SP - 1120

EP - 1122

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 8

ER -